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Abstract We studied the interaction of cis-diammine Pt(II)-
bridged bis-netropsin, cis-diammine Pt(II)-bridged bis-distamy-
cin and oligomethylene-bridged bis-netropsin with synthetic
DNA fragments containing pseudosymmetrical AT-rich nucleo-
tide sequences and compared it with the interaction of the parent
compounds netropsin and distamycin A. For fragments contain-
ing multiple blocks of (A/T)4 and (T/A)4 separated by zero, one,
two and three GC-base pairs, DNase I footprinting and CD
spectroscopy studies reveal that 5P-TTTTAAAA-3P is the
strongest affinity binding site for cis-diammine Pt(II)-bridged
bis-netropsin and bis-distamycin. They both bind less strongly to
a DNA region containing the sequence 5P-AAAATTTT-3P.
Netropsin, distamycin A and oligomethylene-bridged bis-netrop-
sin exhibit far less sequence discrimination.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
There is much interest in design and synthesis of biologi-
cally active compounds that can bind to DNA with a high
a⁄nity and speci¢city. Cell-permeable sequence-speci¢c
DNA-binding ligands have a potential to control gene expres-
sion and to serve as prototypes of gene-selective drugs. Ne-
tropsin and distamycin A are among the best characterized
sequence-speci¢c ligands with respect to their mode of inter-
action with DNA ([1] and literature cited therein). X-ray [2^4]
and NMR studies [5] show that these antibiotics bind in the
minor groove of double-helical DNA at sites of 4 and 5 suc-
cessive AT base pairs [2^5].
An obvious way to enhance the binding speci¢city shown
by netropsin or distamycin A is to synthesize dimer com-
pounds (bis-netropsins and bis-distamycins) in which two
monomers are linked in head-to-head, head-to-tail and tail-
to-tail manners. Since the ¢rst communications on the design
and DNA binding properties of synthetic ligands of this class
[6,7] a considerable progress has been achieved [8^17]. It was
shown that some of these compounds exhibit a high binding
speci¢city and inhibit selectively initiation of transcription di-
rected by certain procaryotic promoters [7]. Bis-linked netrop-
sin derivatives selectively inhibit activity of topoisomeases I
and II [18,19] and HIV-I reverse transcriptase [20]. It was
found that two distamycin (or lexitropsin) molecules can be
packed in the minor groove, with the peptide group of one
drug molecule stacked on the aromatic ring of the other [21^
23]. Antiparallel hairpin motifs containing di¡erent sequences
of N-methylpyrrole and N-methylimidazole residues can rec-
ognize a broad category of nucleotide sequences in the minor
groove [13^17]. Recently it has been reported that two parallel
oligopyrrolecarboxamide strands can be sandwiched in the
minor DNA groove [24].
In the present work, we report on the DNA-binding proper-
ties of cis-diammine Pt(II)-bridged bis-netropsin (6Nt-
Pt(NH3)2-NtC), cis-diammine Pt(II)-bridged bis-distamycin
(6Dst-Pt(NH3)2-DstC) and oligomethylene-bridged bis-ne-
tropsin (6Nt-(CH2)5-NtC) (Fig. 1). Interaction of netropsin
and distamycin with DNA has been previously studied by
quantitative footprinting [8,9]. However, there have been no
reports which examine systematically the a⁄nities of bis-
linked netropsin (distamycin) derivatives to di¡erent AT-rich
sequences. To facilitate comparison of the binding of se-
quence-speci¢c ligands to di¡erent AT-rich sites we have
used cloned synthetic DNA fragments as substrates for foot-
printing studies.
2. Materials and methods
2.1. Ligands
Distamycin A and netropsin were purchased from Sigma. 6Nt-
Pt(NH3)2-NtC, 6Dst-Pt(NH3)2-DstC and 6Nt-(CH2)5-NtC
(Fig. 1) were synthesized and puri¢ed as described elsewhere [25].
The concentrations of 6Nt-Pt(NH3)2-NtC and 6Nt-(CH2)5-NtC
were determined spectrophotometrically, using a value for the molar
absorbance at 297 nm of 42 000 M31 cm31. The concentration of
6Dst-Pt(NH3)2-DstC was determined at 303 nm, using a value
for the molar absorbance of 60 000 M31 cm31. The CD spectra
were recorded on a Jasco Model 720 instrument using 0.1-, 0.2- and
1.0-cm cells.
2.2. DNA fragments and DNase I footprinting studies
The oligonucleotides containing pseudosymmetrical nucleotide se-
quences were synthesized on the phosphoramidite chemistry by using
an automated synthesizer from Applied Biosystems. Each oligonu-
cleotide was cloned in the polylinker region of plasmid pGEM7Z(f+)
(Promega). The ligation mixtures were transformed into Escherichia
coli Sure and successful clones were isolated in the usual way as white
colonies from agar plates containing X-gal and IPTG. The modi¢ed
plasmid containing inserted oligonucleotide was used in a second
round of cloning with another oligonucleotide. The plasmid contain-
ing all the inserts was digested by XbaI restrictase (Promega), labelled
at the XbaI site with [33P]CTP using Klenow fragment (Pharmacia)
and then digested with NsiI restrictase (Promega). DNase I footprint-
ing was performed according to the protocol outlined in [15]. Samples
(5 Wl) of radioactively labelled XbaI-NsiI restriction fragment (around
1.5 WM base pairs) in 10 mM Tris-HCl bu¡er (pH 7.6) were mixed
with a solution (5 Wl) of the appropriate ligand in 10 mM Tris-HCl
bu¡er (pH 7.6) in the presence of 0.5 M NaCl and kept at 20‡C for
FEBS 21133 20-11-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 3 7 9 - 9
1Corresponding authors. G.V.G.: Fax: (7) (95) 1351405.
E-mail: gursky@genome.eimb.rssi.ru. C.Z.: Fax: (49) (3641) 657520.
E-mail: christoph.zimmer@uni-jena.de
FEBS 21133FEBS Letters 439 (1998) 346^350
20 min and then digested with 10 Wl of DNase I solution (0.5 Wg/ml) in
DNase bu¡er (10 mM Tris-HCl bu¡er (pH 7.6), 0.25 M NaCl and
5 mM MnCl2) for 3 min at 20‡C. The reaction was stopped by adding
90 Wl of the solution containing 50 mM Tris-HCl bu¡er (pH 7.5),
0.15 M NaCl, 10 mM EDTA and 10 Wg/ml tRNA.
2.3. Determination of thermodynamic parameters
The occupancy of the 12-mer DNA oligomer containing eight suc-
cessive AT-base pairs by bis-netropsin bound in the extended confor-
mation (R1), hairpin (R2) and dimer (R3) forms can be calculated
from the following equations:
R1  K1m=Z 1
R2  5K2m 2K22 m2=Z 2
R3  2Wm2=Z 3
m  C3OR1  R2  R3 4
W  KdK3 5
Z  1 K1m 5K2m K22 m2 Wm2 6
vD=O  vO1R1  vO2R2  vO3R3 7
where C is the concentration of the ligand; Z is the grand partition
function for the system under study; K1 and K2 are the a⁄nity con-
stants for binding of a bis-netropsin to the 12-mer DNA oligomer in
the extended conformation and hairpin form, respectively; Kd is the
dimerization constant; K3 is the binding constant of dimer species to
the DNA; vD/O is the measured CD amplitude at 310 nm expressed
per mol of DNA oligomer and 1 cm pathlength cell ; O is the molar
concentration of the DNA oligomer; vO1 and vO2 are the molar di-
chroism values for bis-netropsin binding in the extended conformation
and hairpin form, respectively; vO3 is the molar dichroism value of
antiparallel 2:1 complex between bis-netropsin and DNA oligomer.
The molar dichroism values at 310 nm were found to be vO1 = 85 þ 5,
vO2 =35 þ 1, and vO3 = 16 þ 1 [24]. Thermodynamic parameters were
determined from CD titration curves at 310 nm by iterative least
square ¢tting of the experimental plots of vD/O versus C/O to Eqs.
1^7 [24].
3. Results
It is of interest to compare the sequence speci¢city exhibited
by cis-diammine platinum-bridged bis-netropsin (distamycin)
with that of netropsin and distamycin A under the same con-
ditions. In order to accomplish this we used in the footprint-
ing studies a specially constructed DNA fragment containing
a series of potential interaction sites for netropsin, distamycin
A and bifunctional derivatives. Fig. 3 presents an autoradio-
graph of DNase I protection patterns observed in the presence
of various concentrations of 6Nt-Pt(NH3)2-NtC, 6Dst-
Pt(NH3)2-DstC, Nt and Dst. Netropsin and distamycin pro-
tect from DNase I cleavage a series of regions on the DNA
fragment whose sequence is shown in Fig. 2, as is made clear
in Fig. 3. Each protection zone is associated with a cluster of
four or more AT-base pairs. Looking at the results for Pt-
bridged bis-netropsin and bis-distamycin, it can be seen that
only a few protection zones are produced. Clear footprints are
produced around 5P-TTTTAAAA-3P at low ligand concentra-
tions (0.2^0.5 WM), while footprints at sites with sequences 5P-
AAAAATTTTT-3P and 5P-TTTTGAAAA-3P require higher
ligand concentrations. The strongest a⁄nity site has the se-
quence 5P-TTTTAAAA-3P. Some protection at this DNA re-
gion is seen in the presence of 0.1 WM bis-netropsin. Foot-
printing patterns obtained for 6Dst-Pt(NH3)2-DstC do not
di¡er signi¢cantly from those obtained with 6Nt-Pt(NH3)2-
NtC. The binding of 6Dst-Pt(NH3)2-DstC seems to be
more tolerant to insertion of single GC pairs in AT-tracks.
As with bis-netropsin, the preferred binding sequence for Pt-
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Fig. 1. Chemical structures of netropsin (Nt), distamycin A (Dst), cis-diammine Pt(II)-bridged bis-netropsin (6Nt-Pt(NH3)2-NtC), cis-dia-
mmine Pt(II)-bridged bis-distamycin (6Dst-Pt(NH3)2-DstC) and oligomethylene-bridged bis-netropsin (6Nt-(CH2)5-NtC). The arrows indi-
cate directions from the N-terminus to the C-terminus in each peptide fragment.
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bridged bis-distamycin on the DNA fragment is 5P-
TTTTAAAA-3P. However, X-ray-induced cleavage diagrams
show that the most preferred site for binding of 6Dst-
Pt(NH3)2-DstC involves a longer sequence 5P-TXTTTA-
AAYA-3P, where X and Y are either A or T ([11] and unpub-
lished data). Netropsin and distamycin A exhibit far less se-
quence discrimination than Pt-bridged bis-netropsin and bis-
distamycin. Bis-derivatives do not practically bind to DNA
regions in which two blocks of four or ¢ve AT-base pairs
are separated by CC, CG, GC, GG and GGG steps. In con-
trast, netropsin and distamycin bind to clusters of AT-pairs in
all these regions, irrespective, in the ¢rst approximation, of
the £anking sequences. In addition, at low concentrations of
netropsin and distamycin (0.1 WM) clear footprints are pro-
duced around tetramers 5P-AAAT-3P and 5P-AATT-3P. These
sites are not protected by Pt-bridged bis-netropsin (distamy-
cin) at the highest concentrations used (1 WM).
Our observations that DNA regions with symmetry-related
nucleotide sequences 5P-TTTTAAAA-3P and 5P-AAAAT-
TTT-3P have di¡erent a⁄nities for Pt-bridged bis-netropsin
are supported by CD studies on binding of the synthetic lig-
and to 12-mer duplexes with sequences 5P-CGTTTTAA-
AACG-3P (I) and 5P-CGAAAATTTTCG-3P (II). Fig. 4 shows
the CD spectra for complexes between DNA oligomer I and
6Nt-Pt(NH3)2-NtC as well as di¡erence CD spectra ob-
tained by subtracting the CD spectra of DNA oligomers I
and II from the CD spectra of corresponding complexes
with the synthetic ligand. For a complex with duplex I, the
maximum of the CD band occurs at 316 nm. The molar CD
absorbance at 316 nm per mol of DNA oligomer (75 þ 1) is
approximately twice that found for binding of a netropsin
analogue to poly(dA)Wpoly(dT), 33 þ 2 [15]. This indicates
that both monomer fragments of the bis-netropsin molecule
are bound to DNA. Fig. 5 shows the typical plots of the CD
amplitude at 310 nm expressed per mol of DNA oligomer
(vD/O) against the molar ratio of added ligand to the DNA
oligomer (C/O). We found that 6Nt-Pt(NH3)2-NtC binds
more strongly to oligomer I than to oligomer II. The complex
with oligomer I is stable in the presence of 3.0 M NaCl,
whereas the complex with oligomer II is found to be less
resistant to the salt administration. Approximately half of
the total amount of the bis-netropsin complexed with the
duplex II in 1 mM sodium cacodylate bu¡er (pH 7.0) in the
presence of 0.1 M NaCl dissociates in the presence of 0.9 M
NaCl (Fig. 5b). The higher a⁄nity of6Nt-Pt(NH3)2-NtC to
the duplex I can be attributed to the conformational proper-
ties of the DNA oligomer which contains a centrally located
TpA step and may have a widened minor groove [26].
The binding speci¢city of Pt-bridged bis-netropsin and bis-
distamycin may be in£uenced in some way by the cis-diam-
mine platinum group. To check the validity of this proposal
we studied the interaction with the oligomers I and II of
another bis-netropsin (6Nt-(CH2)5-NtC) in which two ne-
tropsin residues were bridged by an aliphatic linker (Fig. 1).
Fig. 5 shows the CD titration curves obtained from binding of
6Nt-(CH2)5-NtC to the oligomers I and II. As before, the
binding approaches saturation when one bis-netropsin mole-
FEBS 21133 20-11-98
Fig. 3. DNase I cleavage protection patterns generated by treatment
of the DNA fragment with DNase I in the presence of increasing
concentrations of 6Nt-Pt(NH3)2-NtC, Nt, 6Dst-(NH3)2-DstC
and Dst. Lanes 1 and 13: Free DNA fragment; lanes 2, 14 and 25:
Maxam-Gilbert’s purine sequence markers; lanes 3, 8, 15 and 20:
DNase I cleavage products of the free DNA; lanes 4^7: cleavage
products generated by DNase I treatment in the presence of Pt-
bridged bis-netropsin at concentrations 1, 0.5, 0.25 and 0.125 WM,
respectively; lanes 9^12: DNase I cleavage products generated in
the presence of 1, 0.5, 0.25 and 0.125 WM netropsin; lanes 16^19:
cleavage products generated in the presence of 1, 0.5, 0.25 and
0.125 WM Pt-bridged bis-distamycin; lanes 21^24: cleavage products
generated in the presence of distamycin at concentrations of 1, 0.5,
0.25 and 0.125 WM, respectively. Sequences on the right side corre-
spond to the oligonucleotide inserts into the DNA fragment.
Fig. 2. Nucleotide sequence of the XbaI-NsiI restriction fragment
derived from of a modi¢ed plasmid pGEM7Z(f+). The strand
shown is the one seen by labelling the fragment at the 3P-end of the
XbaI site. Indicated are the oligonucleotide inserts which serve as
substrates in footprinting studies.
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cule is bound per duplex. Examination of the CD spectral
pro¢les obtained for complexes of 6Nt-Pt(NH3)2-NtC
with duplex II reveals that at occupancy approaching the
saturation level of binding the CD spectra can be well repre-
sented as a linear combination of two reference CD patterns:
the CD spectrum characteristic of bis-netropsin binding in the
extended conformation and CD spectrum corresponding to a
complex containing antiparallel dimer motif. At C/O = 1.2
about 26% of bound bis-netropsin exist as side-by-side dimers
(Fig. 4c). The same situation is observed for complexes of
6Nt-(CH2)5-NtC with the duplex I, but in this case the
fraction of the bis-netropsin bound in a dimer form is even
greater (about 45%). Decomposition of the CD spectrum for a
complex between6Nt-(CH2)5-NtC and DNA oligomer II at
C/O = 1.1 shows that fractions of the extended conformation,
hairpin and dimer forms are 40, 16 and 44%, respectively.
This indicates that each bis-netropsin in the extended confor-
mation, hairpin and dimer forms exhibits di¡erent sequence
preferences. The magnitudes of binding constants determined
from the CD titration curves by iterative least square data
¢tting procedure [24] are consistent with the results of decon-
volution analysis (see legend to Fig. 5). We found that Pt-
bridged bis-netropsin in the extended conformation exhibits
three times higher a⁄nity to DNA oligomer I than to oligo-
mer II. In contrast, 6Nt-(CH2)5-NtC in the extended con-
formation binds to duplexes I and II with nearly the same
a⁄nity. Interestingly, both complexes are stable in the pres-
ence of 3.0 M NaCl (Fig. 5d).
4. Discussion
Footprints produced by Pt-bridged bis-netropsin and bis-
distamycin on the DNA fragment exhibit only a few protec-
tion zones in the presence of 0.25 M NaCl. Each protection
zone corresponds to the preferred interaction site for a syn-
thetic ligand. The strongest a⁄nity site for 6Nt-Pt(NH3)2-
NtC has the sequence 5P-TTTTAAAA-3P [11] which di¡ers
only in one position from that found in a strong interaction
site for 6Nt-Pt(NH3)2-NtC in the regulatory region for hu-
man MPA-kinase gene [27]. The inappropriate expression lev-
el of the gene could be responsible for pathology caused by
Alzheimer disease [27]. Quantitative DNase I footprinting
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Fig. 5. CD titrations of duplexes I (26 WM) and II (17.5 WM) by
6Nt-Pt(NH3)2-NtC (a) and duplexes I (14 WM) and II (14 WM)
by 6Nt-(CH2)5-NtC (c). a and b, Data points from titrations of
duplexes I (1) and II (2), respectively. R and U, Theoretical values
of vD/O calculated from Eqs. 1^7 at di¡erent C/O values, using the
best ¢t values for binding parameters. Panel a: K1 = 6.4U105 M31,
K2 = 5U103 M31 and W = 1.0 M32 for binding to duplex I and
K1 = 1.8U105 M31, K2 = 5U103 M31 and W = 7U109 M32 for bind-
ing to duplex II. Panel c: K1 = 2.2U105 M31, W = 1.6U1010 M32
and K2 = 1.0 M31 for binding to duplex I and K1 = 2.1U105 M31,
K2 = 1.5U104 M31 and W = 3.6U109 M32 for binding to duplex II.
The mean square deviations of the experimental and calculated
vD/O values were 9.4 and 6.5 for complexes of 6Nt-Pt(NH3)2-
NtC with duplexes I and II, respectively, and were 1.1 and 0.6, re-
spectively, for complexes of 6Nt-(CH2)5-NtC with the same du-
plexes. Stabilities of (b) 6Nt-Pt(NH3)2-NtC and (d) 6Nt-(CH2)5-
NtC complexes with duplexes I (a) and II (b) as functions of
NaCl concentration. vO0 is the CD amplitude measured at 310 nm
in the presence of 0.1 M NaCl. vO is the same quantity measured
at higher NaCl concentrations. Concentrations of DNA oligomers
I and II were equal to 17 WM (panel b, C/O = 2) and 12.7 WM (pan-
el d, C/O = 2.6).
Fig. 4. a: CD spectra for complexes of 6Nt-Pt(NH3)2-NtC with
DNA oligomer I (28 WM) at di¡erent molar ratios of 6Nt-
Pt(NH3)2-NtC to the duplex (C/O). The C/O values were as fol-
lows: 0, 0; 1, 0.09; 2, 0.27; 3, 0.55; 4, 0.91; 5, 1.37; 6, 1.91. The
CD spectra were recorded in 1 mM sodium cacodylate bu¡er (pH
7.0) in the presence of 0.1 M NaCl at 20‡C. b: Di¡erence CD pat-
terns calculated for binding of 6Nt-Pt(NH3)2-NtC in the extended
conformation (1), hairpin (2) and dimer (3) forms. c: Decomposi-
tion of the di¡erence CD patterns I and II obtained by subtracting
the CD spectra of oligomers I (19 WM) and II (13 WM) from the
spectra of their complexes with 6Nt-Pt(NH3)2-NtC at C/O values
of 1.4 and 1.2, respectively. The experimental and calculated CD
patterns are shown by solid and dotted lines, respectively. The con-
tents of the extended conformation, hairpin and dimer forms were
0.82, 0.18 and zero for 6Nt-Pt(NH3)2-NtC complexed with the
duplex I and were 0.74, zero and 0.26, respectively, for 6Nt-
Pt(NH3)2-NtC bound to the duplex II.
S.L. Grokhovsky et al./FEBS Letters 439 (1998) 346^350 349
showed that tetramers AATT and AAAA are better binding
sites for distamycin and netropsin than TTAA and TATA
[28]. Pt-bridged bis-netropsin and bis-distamycin exhibit a
higher binding speci¢city than netropsin and distamycin, in
spite of the fact that two monomers in the bis-netropsin mol-
ecule have a lower a⁄nity for DNA than netropsin itself. At
low extents of binding both Pt-bridged bis-netropsin and bis-
distamycin bind to DNA predominantly in the extended con-
formation. Each bound molecule covers approximately one
turn of the DNA helix in such a way that both netropsin
(distamycin)-like fragments are implicated in speci¢c interac-
tion with DNA base pairs. The observed preference of Pt-
bridged bis-netropsin and bis-distamycin for binding to
DNA regions with sequences 5P-TTTTAAAA-3P or 5P-
TTTTTAAAAA-3P and their lower a⁄nities to sites in which
blocks of Ts and As are interchanged can be explained by
variation in the minor groove width and/or sequence-depend-
ent deformability inherent to these DNA regions. The wider
minor groove is observed in the centre of the dodecamer du-
plex d(CGCGTTAACGCG)2 as compared with the width of
the minor groove in the oligomer d(CGCGAATTCGCG)2
[26]. It is well-documented that TpA steps are associated
with the capacity of DNA to be bent in such a way that the
minor groove is widened upon interaction with the groove
binders [29,30]. The increased width of the minor groove
might be needed to accommodate simultaneously the cis-
diammine platinum residue and two netropsin-like fragments
of the bis-netropsin molecule in the minor groove and to form
speci¢c contacts with both parts of the DNA target site.
6Nt-(CH2)5-NtC containing a £exible aliphatic linker ex-
hibits less sequence discrimination.
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